University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Evaluating Cascade Communication Methods

Active, not recruiting

Conditions: BRCA2 Mutation
BRCA1 Mutation

First Posted Date: 2020-06-11

Last Posted Date: 2025-04-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT04428736

Locations: 🇺🇸
Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Retreatment With CTL019/CTL119

Phase 1

Not yet recruiting

Conditions: Lymphoma, B-Cell

Interventions: Drug: CD19 redirected autologous T cells (CTL019 or CTL119 cells)

First Posted Date: 2020-06-09

Last Posted Date: 2024-08-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 12

Registration Number: NCT04419909

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Project Resurgence Communication Trial

Not Applicable

Completed

Conditions: Communication Research

Interventions: Other: Communication type

First Posted Date: 2020-06-05

Last Posted Date: 2021-10-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11120

Registration Number: NCT04418947

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Eating Condition

First Posted Date: 2020-06-04

Last Posted Date: 2025-03-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 17

Registration Number: NCT04414644

Locations: 🇺🇸
Center for Weight and Eating Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Cyclosporine in Patients With Moderate COVID-19

Phase 1

Completed

Conditions: COVID-19

Interventions: Drug: Cyclosporine

First Posted Date: 2020-06-02

Last Posted Date: 2022-01-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11

Registration Number: NCT04412785

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluation of a Decision Aid for Early Pregnancy Loss

Not Applicable

Completed

Conditions: Early Pregnancy Loss

Interventions: Other: Healthwise Decision Aid
Other: Control informational handout

First Posted Date: 2020-06-01

Last Posted Date: 2021-03-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 60

Registration Number: NCT04410029

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Tasquinimod
Drug: IRd chemotherapy

First Posted Date: 2020-05-28

Last Posted Date: 2025-02-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 34

Registration Number: NCT04405167

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Individualized Closed Loop TMS for Working Memory Enhancement

Not Applicable

Completed

Conditions: Memory

Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

First Posted Date: 2020-05-26

Last Posted Date: 2024-07-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 26

Registration Number: NCT04402294

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls

Early Phase 1

Recruiting

Conditions: Opioid Use
HIV Infections

Interventions: Drug: [18F]NOS

First Posted Date: 2020-05-26

Last Posted Date: 2025-04-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 60

Registration Number: NCT04401917

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.

Phase 1

Completed

Conditions: COVID-19

Interventions: Biological: COVID-19 Convalescent Plasma

First Posted Date: 2020-05-21

Last Posted Date: 2022-04-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 80

Registration Number: NCT04397757

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy